TORONTO, May 1, 2014 (GLOBE NEWSWIRE) -- Epcylon Technologies, Inc. (OTCBB:PRFC) ("Epcylon" or the "Company") is pleased to announce that it has closed and received the $2 million USD Series A funding round. Epcylon will utilize these funds to qualify for graduation to the QX exchange and has initiated the process for listing. The company currently trades on OTCBB.
"Moving to the QX Exchange is a natural progression of our business plan and model. This closed funding round allows us to take the company to the next level. We are very fortunate to have for-seeing investors who support our mission," said Peter George, CEO of Epcylon.
About the OTC QX
The OTC QX is the premier tier of the U.S. Over-the-Counter ("OTC") marketplace. The OTC QX is an innovative and competitive platform that provides the highest level of visibility and access to investors in the OTC market. The OTC QX is fully electronic and gives investors access through all major online and full-service brokerage firms in the U.S., including Schwab, E*Trade, Scottrade, TD Ameritrade and Fidelity to name a few. Trades are settled and cleared in the U.S. similar to any NASDAQ or NYSE stock, and trade reports are distributed through Yahoo, Bloomberg, Reuters and most other financial data providers.
About Epcylon Technologies, Inc.
Epcylon (OTCBB:PRFC) is an innovator in four fields: intuitive trading software; applications that assist fundraising for charities & sports trading; energy efficient lighting technologies; and sustainable building materials. Please visit us at http://www.epcylon.com
Forward-Looking Statements
You should not place undue reliance on forward-looking statements in this press release. This press release contains forward-looking statements that involve risks and uncertainties. Words such as "will," "anticipates," "believes," "plans," "goal," "expects," "future," "intends," and similar expressions are used to identify these forward-looking statements. Actual results could differ materially from those anticipated in these forward-looking statements for many reasons, including the risks we face as described in this press release. For further information about Epcylon Technologies Inc., please refer to its website at http://www.epcylon.com